[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341211-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-341211-en":123},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","insights-for-clinical-management-from-the-real-life-data-of-the-centralized-west-of-scotland-biliary-cancer-clinic","Insights for clinical management - from the real-life data of the centralized West of Scotland biliary cancer clinic","","Real-life evidence for biliary tract cancers (BTC) is crucial as novel therapies expand and socioeconomic impacts must be assessed for national licensing. An audit evaluated the first two years of a centralized West-of-Scotland BTC clinic (Sep 2019–Sep 2021) including 122 patients across cholangiocarcinoma, gallbladder cancer, and ampulla of Vater carcinoma. Results reported surgery eligibility, recurrence rates, and systemic anti-cancer treatment lines. Findings suggest reflex genomic profiling may be cost-effective mainly from the second-line setting.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/insights-for-clinical-management-from-the-real-life-data-of-the-centralized-west-of-scotland-biliary-cancer-clinic/341211/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/insights-for-clinical-management-from-the-real-life-data-of-the-centralized-west-of-scotland-biliary-cancer-clinic/341211.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What did the study conclude about surgery eligibility and systemic treatment lines?","Question",{"text":63,"@type":64},"About 30% of BTC were eligible for curative surgery, and among advanced BTC patients, 58% and 20% received first- and second-line SACT respectively. The data also suggest reflex genomic profiling may be cost-effective only when molecularly driven strategies are limited to second line.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},341211,1790759919,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,112,115,119],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":108,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},9,"Religion & Spirituality",20,"religion-spirituality",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":113,"show_sort_weight":110,"slug":114},"World Cup","world-cup",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":116,"slug":118},10,"Lifestyle","lifestyle",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":89,"slug":122},19,"General","general",{"code":4,"msg":74,"data":124},{"doc_id":71,"user_id":125,"nickname":42,"user_avatar":126,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Zanuso etal. BMC Cancer (2024) 24:597 [https://doi.org/10.1186/s12885-024-12279-6](https://doi.org/10.1186/s12885-024-12279-6)  \nBMC Cancer  \nRESEARCH Open Access  \nInsights for clinical management   \nfrom the real-life data of the centralized West of Scotland biliary cancer clinic  \nValentina Zanuso 1,2, Tamsin Nash3,4, Raffaella Casolino 1, Gregory Armstrong4, Ona Pall ise3,4, Jen Milne3,4 and Chiara Braconi 1,3,5*  \nAbstract  \nBackground With the increasing of novel therapeutics for the treatment of Biliary Tract Cancers (BTC), and the need to assess their socio-economic impacts for national licence approvals, it is as important as ever to have real-life data in national populations.  \nMethods and results We performed an audit of the first 2 year-activity (Sep 2019-Sep 2021) of the centralized West-of-Scotland-BTC clinic. 122 patients accessed the service, including 68% with cholangiocarcinoma (CCA), 27% with gallbladder cancer (GBC), and 5% with ampulla ofVater carcinoma with biliary phenotype (AVC) . Median age at diagnosis was 66 (28–84), with 30% of newly diagnosed patients being younger than 60 years-old. Thirty-five cases (29%) underwent surgery, followed by adjuvant-chemotherapy in 66% . 60% had recurrent disease (80% with distant relapse) . Sixty-four patients (58%) started first-line Systemic-AntiCancer-Treatment (SACT) . Of these, 37% received second line SACT, the majority of which had iCCA and GBC. Thirty-% of those who progressed received third line SACT.  \nConclusions About 30% of BTC were eligible for curative surgery. Fifty-eight and twenty% of the overall cohort of advanced BTC patients received first and second line SACT. Our data suggest that reflex genomic profiling may not be cost-effective until molecularly driven strategies are limited to second line setting.  \nKeywords Cholangiocarcinoma, Biliary cancer, Genomic profiling, Systemic treatment, Chemotherapy, Scotland  \n*Correspondence: Chiara Braconi  \n[chiara.braconi@glasgow.ac.uk](chiara.braconi@glasgow.ac.uk)  \n1School of Cancer Sciences, University of Glasgow, G61 1QH Glasgow, UK 2Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy  \n3Beatson West of Scotland Cancer Centre, G12 0YN Glasgow, UK 4NHS Greater Glasgow and Clyde, Glasgow, UK 5CRUK-Scotland Cancer Centre, Glasgow-Edinburgh, UK  \nIntroduction  \nBiliary tract cancers (BTCs) are a group of rare and aggressive diseases whose incidence is increasing worldwide [1]. BTCs include cholangiocarcinoma (CCA) [subclassified as intrahepatic (iCCA), peri-hilar (pCCA) or distal (dCCA)], gallbladder cancer (GBC) and carcinoma of the Ampulla ofVater (AVC) [1]. Combined hepatocellular carcinoma (HCC) and CCA is another rare type ofbiliary cancer, associated with a dismal prognosis. Several controlled and randomized clinical trials have supported the benefit of additional drugs in selected populations of BTC patients, mainly focusing on targeted agents in  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecomm","cbCaijc0PZykEkXh","https://ap.wps.com/l/cbCaijc0PZykEkXh","pdf",1615973,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What did the study conclude about surgery eligibility and systemic treatment lines?\",\"answer\":\"About 30% of BTC were eligible for curative surgery, and among advanced BTC patients, 58% and 20% received first- and second-line SACT respectively. The data also suggest reflex genomic profiling may be cost-effective only when molecularly driven strategies are limited to second line.\"}]","Insights for clinical management - from the real-life data of the centralized West of Scotland biliary cancer clinic | PDF",1790040919,25,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1757317e8041f069934bbf4e00ba7f7c.webp",983,1310,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f354a9db19d90817ae6dd50665bbd463.webp",982,1309,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/651e14db32ad6bb8fbc0144a2418cc4b.webp",981,1308,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/898ff6525504c1b670ab0dd7349384df.webp",980,1306]